Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
October 18, 2021 at 05:27 am
Share
Teyi Pharmaceutical Group Co.,Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 525.47 million compared to CNY 433.08 million a year ago. Revenue was CNY 525.47 million compared to CNY 433.08 million a year ago. Net income was CNY 102.87 million compared to CNY 28.77 million a year ago. Basic earnings per share from continuing operations was CNY 0.51 compared to CNY 0.14 a year ago. Diluted earnings per share from continuing operations was CNY 0.51 compared to CNY 0.14 a year ago.
TEYI PHARMACEUTICAL GROUP CO., LTD, formerly Guangdong Taicheng Pharmaceutical Co., Ltd., is principally engaged in the production and sale of pharmaceuticals. The Company primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The Company's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.
TEYI PHARMACEUTICAL GROUP CO.,LTD 
